Rockwell Med (RMTI) Stock Statistics & Valuation Metrics

Rockwell Med has a market cap or net worth of $32.90M. The enterprise value is $36.15M.

Rockwell Med has 34,174,686 shares outstanding. The number of shares has decreased by -2.65% in one year.

Rockwell Med’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 1.35%.

The current PE Ratio of Rockwell Med is -132.00. Rockwell Med’s PEG ratio is -2.04.

In the last 12 months, Rockwell Med had revenue of 101.49M and earned -480.00K in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was 4.20M and capital expenditures -1.01M, giving a free cash flow of 3.19M billion.

Rockwell Med pays an annual dividend of ―, resulting in a dividend yield of ―

Rockwell Med upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.

Rockwell Med as a current ratio of 2.63, with Debt / Equity ratio of 41.54%

In the past 12 months, Rockwell Med has paid 0.00 in taxes.

Rockwell Med EV to EBITDA ratio is 20.73, with an EV/FCF ratio of 19.19.

Rockwell Med has $21.60M in cash and marketable securities with $13.54M in debt, giving a net cash position of -$8.07M billion.

Gross margin is 17.23%, with operating margin of 0.60%, and net profit margin of -0.47%.

The average price target for Rockwell Med is $4.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy